6
total announcements
LOTUSEYE.NS · 15 min delayed
Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited has launched 'Lotus Optique', a new optical store at its SITRA campus in Coimbatore, offering a curated selection of branded frames and contemporary eye wear, supported by the company's clinical expertise and eye care environment.
Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited has published a copy of newspaper advertisements for their standalone unaudited financial results for the quarter ended June 30, 2026, as approved by the Board of Directors on August 10, 2026.
Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited has submitted its Standalone Unaudited Financial Results for the quarter ended June 30, 2026, with a net profit of Rs. 61.37 lakhs. The company's revenue from operations was Rs. 1,705.71 lakhs, and its total income was Rs. 1,726.79 lakhs. The company's expenses were Rs. 1,625.44 lakhs, resulting in a profit before exceptional items and tax of Rs. 101.35 lakhs. Exceptional items represented the profit on sale of property, plant, and equipment.
Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited has received a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming that securities received for dematerialization have been confirmed or rejected and listed on stock exchanges.
Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited has announced the submission of a disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation primarily relates to the encumbrance or pledging of shares by promoters or persons in control. The announcement confirms the company's compliance with regulatory requirements to report such share-related information to the exchange. No specific financial figures or direct decisions by the company are detailed in this filing; it merely reports the regulatory submission. Investors should refer to the full disclosure for specific details regarding any share encumbrances.